Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick W Quelle

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Cycle (Georgetown, Tex.)|March 14, 2014
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53Sara M Reed, Jussara Hagen, Van S Tompkins, et al.
Molecular and Cellular Biology|February 3, 2005
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its functionChandrashekhar Korgaonkar, Jussara Hagen, Van Tompkins, et al.
JCI Insight|November 25, 2016
Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanismLarry N Agbor, Stella-Rita C Ibeawuchi, Chunyan Hu, et al.
JCI Insight|March 30, 2017
Retinol-binding protein 7 is an endothelium-specific PPAR<b>γ</b> cofactor mediating an antioxidant response through adiponectinChunyan Hu, Henry L Keen, Ko-Ting Lu, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth MuscleMasashi Mukohda, Ko-Ting Lu, Deng-Fu Guo, et al.
JCI Insight|June 12, 2019
Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertensionLarry N Agbor, Anand R Nair, Jing Wu, et al.
The Journal of Clinical Investigation|March 22, 2019
RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activityMasashi Mukohda, Shi Fang, Jing Wu, et al.
JCI Insight|March 31, 2022
RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerizationShi Fang, Jing Wu, John J Reho, et al.
Cancer Research|October 3, 2014
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent mannerJussara Hagen, Viviane P Muniz, Kelly C Falls, et al.
The Journal of Clinical Investigation|February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growthShaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Cycle (Georgetown, Tex.)|March 14, 2014
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53Sara M Reed, Jussara Hagen, Van S Tompkins, et al.
Molecular and Cellular Biology|February 3, 2005
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its functionChandrashekhar Korgaonkar, Jussara Hagen, Van Tompkins, et al.
JCI Insight|November 25, 2016
Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanismLarry N Agbor, Stella-Rita C Ibeawuchi, Chunyan Hu, et al.
JCI Insight|March 30, 2017
Retinol-binding protein 7 is an endothelium-specific PPAR<b>γ</b> cofactor mediating an antioxidant response through adiponectinChunyan Hu, Henry L Keen, Ko-Ting Lu, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth MuscleMasashi Mukohda, Ko-Ting Lu, Deng-Fu Guo, et al.
JCI Insight|June 12, 2019
Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertensionLarry N Agbor, Anand R Nair, Jing Wu, et al.
The Journal of Clinical Investigation|March 22, 2019
RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activityMasashi Mukohda, Shi Fang, Jing Wu, et al.
JCI Insight|March 31, 2022
RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerizationShi Fang, Jing Wu, John J Reho, et al.
Cancer Research|October 3, 2014
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent mannerJussara Hagen, Viviane P Muniz, Kelly C Falls, et al.
The Journal of Clinical Investigation|February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growthShaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Pageof 2